関節リウマチ, 体軸型脊椎関節炎, 乾癬性関節炎, 乾癬 における生物学的製剤と疾患修飾薬の薬剤継続率– DANBIO および DERMBIO レジストリ
Semin Arthritis Rheum. 2022 doi: 10.1016/j.semarthrit.2022.151979
The authors reviewed drug survival of therapies across common inflammatory skin and joint conditions from national registries. The findings highlighted that despite the overlapping pathogenesis of these conditions there was little similarity in drug survival. This reinforces the need for an individualised treatment approach consistent with the underlying disease, patient profile and treatment history.